Products

RateCraft

Calculate exactly what to charge without underpricing

zippy-basbousa-2ab155.netlify.app HR & Careers / Freelance & Talent Marketplaces

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$19/mo
Higher than 53% of peersNiche median $15/mo
Creators
Codigo Furia
No social account linked
Launched
34d ago
2026-10-14 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Calculate what to charge without underpricing

    Oct 14 · 34d agoLaunch page

    At the time: <5K visits/mo

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2018-05-08

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pro
Unknown

Trial: None · Observed 2026-11-07 · Source page

Entry price $19/mo, Higher than 53% of peers; “Freelance & Talent Marketplaces” median is $15/mo.View pricing benchmark

Pages & changes

Tracked since 2026-10-14

Key pages

Weekly snapshots
Home

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does RateCraft cost?
Pro: Unknown. Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does RateCraft get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is RateCraft and what platforms does it support?
RateCraft is catalogued under Freelance & Talent Marketplaces: Calculate exactly what to charge without underpricing. Supported platforms: Web.

Related products in this category

HR & Careers / Freelance & Talent Marketplaces

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.